Our prediction model provides a useful framework for conveying tailored risk information simply and identifying women who may receive enhanced benefit from specific intervention strategies because ...

HealthDay News — From 2003 to 2017, cancer incidence rates increased for several cancer types, with increases in younger and older adults for many cancers, according to a study published online Oct.

Compared to no legalization, medical marijuana legalization with state-run dispensaries appears to increase the risk of adverse hospital events among cancer patients receiving surgery.

The EXCALIBER-RRMM study evaluated the efficacy and safety of iberdomide, an investigational cereblon E3 ligase modulator, in combination with dexamethasone and daratumumab in adults with RRMM.

A review of JADER and FAERS databases identified common adverse effects for 3 antibody-drug conjugates with the same type of payload.

Researchers sought to determine whether brexucabtagene autoleucel would improve response rates among patients with relapsed or refractory CLL.

Ultra-low-pass whole genome sequencing (ULP-WGS) of circulating tumor DNA appears to provide important prognostic information regarding patients with large B-cell lymphoma (LBCL), according to ...

An analysis of 5 machine-learning algorithms identified predictors for moderate-to-severe cancer-related fatigue in patients with CRC undergoing chemotherapy.

Minimal residual disease (MRD)-guided retreatment with anti-CD20 antibodies effectively lowers MRD levels and delays clinical relapse in patients with high-risk chronic lymphocytic leukemia (CLL), ...

N. Gopalakrishna Iyer, MBBS, PhD, noting that the researchers were “quite surprised” by the overall survival achieved in the control arm, given the real-world setting of the trial.

HealthDay News — Many people with cancer get directly involved in prior authorization (PA), often facing substantial time burdens, according to a study presented at the 2025 American Society of ...

Researchers suggest that tailoring interventions to symptom clusters and chemotherapy course may be best management strategy.